Medicinal composition for treating chronic hepatopathy, and its application
A technology for chronic hepatitis and drugs, which is applied in the field of pharmaceutical compositions for the treatment of chronic liver diseases, and can solve problems such as side effects, poor stability, and difficult quality control
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0019] The optimal ratio of the composition for reducing liver collagen content was obtained by using DMN-induced rat liver fibrosis model and orthogonal design analysis.
[0020] 1. Materials and methods:
[0021] 1. Animals
[0022] 160 Wistar male rats (40 in the normal group and 120 in the model group), clean grade, weighing (150±10) g, were provided by the Shanghai Experimental Animal Center of the Chinese Academy of Sciences. Animals were reared, modeled and observed in a clean animal room in the Experimental Animal Center of Shanghai University of Traditional Chinese Medicine, with free access to drinking water.
[0023] 2. Main reagents and equipment
[0024] Dimethylnitrosamine (Dimethylnitrosamine, DMN) and hydroxyproline (hydroxyproline, Hyp) standard products, products of Tokyo Chemical Industry Co., Ltd.; liver function kits used were purchased from Nanjing Jiancheng Biological Reagent Company; Image-Pro Plus6 .1 Professional image analysis software was purchas...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com